Patents Assigned to Advanced Inhalation Therapies (AIT) Ltd.
-
Patent number: 10987377Abstract: Methods and devices for treating excess mucus accumulation in mammals by administering gaseous inhaled nitric oxide or nitric oxide releasing compounds as a mucolytic agent or expectorant are provided. Delivery of gaseous nitric oxide can be made nasally or orally and is preferably substantially coincident with inhalation of the mammal or based on a synchronous parameter of the mammal's respiratory cycle. Varying therapeutic profiles may be used for the delivery of gaseous nitric oxide depending on the severity of the excess mucus accumulation. Parameters for the therapeutic profiles may include flow rate of nitric oxide containing gas, duration of administration of nitric oxide containing gas, number of breaths for which nitric oxide containing gas is to be administered, and concentrations of therapeutic NO delivered to the airways.Type: GrantFiled: January 31, 2018Date of Patent: April 27, 2021Assignee: Advanced Inhalation Therapies (AIT), Ltd.Inventors: Bruce R. Murray, Christopher C. Miller, Douglas R. Hole, Bryan Perry
-
Publication number: 20170239289Abstract: The present invention provides a method for treating a disease in a human subject in need thereof, wherein the disease is selected from the group consisting of inflammation, bronchiolitis and cystic fibrosis, and wherein the method comprises repeatedly administering to the human subject a gas mixture comprising nitric oxide at a concentration from about 144 to about 176 ppm for a first period of time, followed by a gas mixture containing no nitric oxide for a second period of time, wherein the administration is repeated for a time sufficient to: a) reduce the level of at least one inflammatory biomarker in the human subject when compared to the level of the inflammatory biomarker prior to the administration; b) reduce the microbial density by 1 to 2 log units as measured by colony forming units in the human subject when compared to the microbial density prior to the administration; or c) a combination thereof.Type: ApplicationFiled: August 24, 2015Publication date: August 24, 2017Applicant: Advanced Inhalation Therapies (AIT) Ltd.Inventors: Yossef Av-Gay, David Greenberg, Racheli Vizman
-
Publication number: 20170143758Abstract: A method of treating a human subject which is effected by intermittent inhalation of gaseous nitric oxide at a concentration of at least 160 ppm is disclosed. The method can be utilized for treating a human subject suffering from, or prone to suffer from, a disease or disorder that is manifested in the respiratory tract, or from a disease or disorder that can be treated via the respiratory tract. The disclosed method can be effected while monitoring one or more of on-site and off-site parameters such as vital signs, methemoglobin levels, pulmonary function parameters, blood chemistry and hematological parameters, blood coagulation parameters, inflammatory marker levels, liver and kidney function parameters and vascular endothelial activation parameters, such that no substantial deviation from a baseline in seen in one or more of the monitored parameters.Type: ApplicationFiled: January 4, 2017Publication date: May 25, 2017Applicant: Advanced Inhalation Therapies (AIT) Ltd.Inventors: David Greenberg, Yossef Av-Gay
-
Publication number: 20170065631Abstract: The present invention relates to a method of treating a human subject suffering from a disease or disorder that is manifested in the respiratory tract or a disease or disorder that can be treated via the respiratory tract, the disease or disorder being associated with a nosocomial infection, the method including subjecting the subject to intermittent inhalation of gNO at a concentration of at least 160 ppm, thereby treating the disease or disorder.Type: ApplicationFiled: September 22, 2016Publication date: March 9, 2017Applicant: Advanced Inhalation Therapies (AIT) Ltd.Inventors: Yossef Av-Gay, David Greenberg, Racheli Vizman
-
Publication number: 20150272988Abstract: A method of treating a human subject which is effected by intermittent inhalation of gaseous nitric oxide at a concentration of at least 160 ppm is disclosed. The method can be utilized for treating a human subject suffering from, or prone to suffer from, a disease or disorder that is manifested in the respiratory tract, or from a disease or disorder that can be treated via the respiratory tract. The disclosed method can be effected while monitoring one or more of on-site and off-site parameters such as vital signs, methemoglobin levels, pulmonary function parameters, blood chemistry and hematological parameters, blood coagulation parameters, inflammatory marker levels, liver and kidney function parameters and vascular endothelial activation parameters, such that no substantial deviation from a baseline in seen in one or more of the monitored parameters.Type: ApplicationFiled: March 7, 2013Publication date: October 1, 2015Applicant: Advanced Inhalation Therapies (AIT) Ltd.Inventors: Yossef Av-Gay, Christopher C. Miller, David Greenberg
-
Publication number: 20150034084Abstract: A method of treating a human subject which is effected by intermittent inhalation of gaseous nitric oxide at a concentration of at least 160 ppm is disclosed. The method can be utilized for treating a human subject suffering from, or prone to suffer from, a disease or disorder that is manifested in the respiratory tract, or from a disease or disorder that can be treated via the respiratory tract. The disclosed method can be effected while monitoring one or more of on-site and off-site parameters such as vital signs, methemoglobin levels, pulmonary function parameters, blood chemistry and hematological parameters, blood coagulation parameters, inflammatory marker levels, liver and kidney function parameters and vascular endothelial activation parameters, such that no substantial deviation from a baseline in seen in one or more of the monitored parameters.Type: ApplicationFiled: March 7, 2013Publication date: February 5, 2015Applicant: Advanced Inhalation Therapies (AIT) Ltd.Inventors: Yossef Av-Gay, Christopher C. Miller, David Greenberg